DK1976538T3 - Farmaceutisk formulering til behandling af slidgigt indeholdende clodronsyre og hyaluronsyre - Google Patents

Farmaceutisk formulering til behandling af slidgigt indeholdende clodronsyre og hyaluronsyre

Info

Publication number
DK1976538T3
DK1976538T3 DK06841087T DK06841087T DK1976538T3 DK 1976538 T3 DK1976538 T3 DK 1976538T3 DK 06841087 T DK06841087 T DK 06841087T DK 06841087 T DK06841087 T DK 06841087T DK 1976538 T3 DK1976538 T3 DK 1976538T3
Authority
DK
Denmark
Prior art keywords
acid
treatment
pharmaceutical formulation
hyaluronic acid
osteoarthritis containing
Prior art date
Application number
DK06841087T
Other languages
English (en)
Inventor
Sergio Rosini
Silvia Trasciatti
Original Assignee
Abiogen Pharma Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Abiogen Pharma Spa filed Critical Abiogen Pharma Spa
Application granted granted Critical
Publication of DK1976538T3 publication Critical patent/DK1976538T3/da

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/726Glycosaminoglycans, i.e. mucopolysaccharides
    • A61K31/728Hyaluronic acid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/66Phosphorus compounds
    • A61K31/662Phosphorus acids or esters thereof having P—C bonds, e.g. foscarnet, trichlorfon
    • A61K31/663Compounds having two or more phosphorus acid groups or esters thereof, e.g. clodronic acid, pamidronic acid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M5/00Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
    • A61M5/178Syringes
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • A61P19/02Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • A61P19/04Drugs for skeletal disorders for non-specific disorders of the connective tissue
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Dermatology (AREA)
  • Molecular Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Biomedical Technology (AREA)
  • Vascular Medicine (AREA)
  • Anesthesiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hematology (AREA)
  • Rheumatology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Immunology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Medicinal Preparation (AREA)
DK06841087T 2005-12-29 2006-12-21 Farmaceutisk formulering til behandling af slidgigt indeholdende clodronsyre og hyaluronsyre DK1976538T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT002515A ITMI20052515A1 (it) 2005-12-29 2005-12-29 Formulazione farmaceutica per il trattamento della osteoartrite
PCT/EP2006/012367 WO2007073921A1 (en) 2005-12-29 2006-12-21 Pharmaceutical formulation for the treatment of osteoarthritis containing clodronic acid and hyaluronic acid

Publications (1)

Publication Number Publication Date
DK1976538T3 true DK1976538T3 (da) 2010-01-11

Family

ID=36648609

Family Applications (1)

Application Number Title Priority Date Filing Date
DK06841087T DK1976538T3 (da) 2005-12-29 2006-12-21 Farmaceutisk formulering til behandling af slidgigt indeholdende clodronsyre og hyaluronsyre

Country Status (21)

Country Link
US (4) US20090042833A1 (da)
EP (1) EP1976538B1 (da)
JP (1) JP2009522218A (da)
KR (2) KR20140107651A (da)
AT (1) ATE446763T1 (da)
AU (1) AU2006331019B2 (da)
CA (1) CA2646974C (da)
CY (1) CY1109541T1 (da)
DE (1) DE602006010111D1 (da)
DK (1) DK1976538T3 (da)
ES (1) ES2333615T3 (da)
HK (1) HK1123986A1 (da)
IT (1) ITMI20052515A1 (da)
NO (1) NO340794B1 (da)
NZ (1) NZ569420A (da)
PL (1) PL1976538T3 (da)
PT (1) PT1976538E (da)
RU (1) RU2414908C2 (da)
SI (1) SI1976538T1 (da)
WO (1) WO2007073921A1 (da)
ZA (1) ZA200805598B (da)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2011311859B2 (en) * 2010-10-07 2015-06-04 National Cheng Kung University Use of hyaluronan for promoting angiogenesis
CN118161529A (zh) 2014-11-07 2024-06-11 胞外体干细胞株式会社 用于成脂分化诱导、脂肪组织再生、皮肤美白或改善皱纹的包含干细胞来源外泌体的组合物
KR101706642B1 (ko) 2015-02-04 2017-02-17 주식회사 엑소스템텍 연골세포로 분화되고 있는 줄기세포로부터 추출된 엑소좀을 포함하는 연골세포 분화 유도 또는 연골조직 재생용 조성물
IT201600123773A1 (it) 2016-12-06 2018-06-06 Abiogen Pharma Spa Composizione per il trattamento dell’osteoartrosi
IT202100023894A1 (it) * 2021-09-16 2023-03-16 Professional Derma Sa Composizione per utilizzo in campo ortopedico

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1187828B (it) 1985-05-24 1987-12-23 Gentili Ist Spa Composizione farmaceutica a base di difosfonati per il trattamento dell aretrosi
JP2001253827A (ja) * 2000-02-15 2001-09-18 Pfizer Prod Inc 骨粗鬆症を治療するための組成物および方法
WO2001085217A1 (en) * 2000-05-05 2001-11-15 F. Hoffmann-La Roche Ag Gel-like pharmaceutical composition for subcutaneous administration comprising bisphosphonic acids or their salts
JP4879482B2 (ja) * 2002-05-17 2012-02-22 ワイス・エルエルシー 骨原性タンパク質を送達するための注入可能な固体ヒアルロン酸キャリア
KR100648515B1 (ko) * 2004-05-04 2006-11-27 (주)아모레퍼시픽 비스포스포네이트-함유 고분자 미립구를 포함하는 골-관련질환 치료 또는 예방용 서방 효과를 갖는 주사제

Also Published As

Publication number Publication date
NO340794B1 (no) 2017-06-19
US20140371170A1 (en) 2014-12-18
KR101470608B1 (ko) 2014-12-09
RU2008126108A (ru) 2010-01-10
AU2006331019A1 (en) 2007-07-05
KR20140107651A (ko) 2014-09-04
US20090042833A1 (en) 2009-02-12
US20180185407A1 (en) 2018-07-05
ZA200805598B (en) 2009-11-25
ATE446763T1 (de) 2009-11-15
SI1976538T1 (sl) 2010-01-29
CA2646974C (en) 2013-06-11
PL1976538T3 (pl) 2010-03-31
DE602006010111D1 (de) 2009-12-10
RU2414908C2 (ru) 2011-03-27
PT1976538E (pt) 2009-12-07
US9943540B2 (en) 2018-04-17
CY1109541T1 (el) 2014-08-13
ITMI20052515A1 (it) 2007-06-30
CA2646974A1 (en) 2007-07-05
EP1976538A1 (en) 2008-10-08
JP2009522218A (ja) 2009-06-11
EP1976538B1 (en) 2009-10-28
WO2007073921A1 (en) 2007-07-05
US20200147126A1 (en) 2020-05-14
NO20082848L (no) 2008-08-27
ES2333615T3 (es) 2010-02-24
KR20080082657A (ko) 2008-09-11
AU2006331019B2 (en) 2012-03-22
AU2006331019A2 (en) 2009-01-22
HK1123986A1 (en) 2009-07-03
NZ569420A (en) 2010-05-28

Similar Documents

Publication Publication Date Title
ATE470443T1 (de) Indol-1-yl-essigsäurederivate
EA201170772A1 (ru) Органические соединения
WO2007076085A3 (en) Fused pyrimidones and thiopyrimidones, and uses thereof
EA200870217A1 (ru) 4-арил-2-аминопиримидины или 4-арил-2-аминоалкилпиримидины в качестве модуляторов jak-2 и содержащие их фармацевтические композиции
MX2009004714A (es) Derivados de pirazol fusionado 3-aminocarbonilo sustituidos como moduladores de proteina cinasa.
CY1110813T1 (el) Χημικες ενωσεις
NO20064584L (no) Tetrahydropyridoindolderivater
UY31673A1 (es) "derivados heterocíclicos de urea y métodos de uso de los mismos-211"
TW200738659A (en) Novel compounds
NO20074823L (no) Rasagilin-formuleringer med forbedret innholdsensartethet
NO20075111L (no) Farmasoytisk sammensetning
EA200802184A1 (ru) Фармацевтические композиции с ингибиторами dpp iv
SG161318A1 (en) Heterocyclic inhibitors of mek and methods of use thereof
WO2006086562A3 (en) Phenylazetidinone derivatives
CY1109916T1 (el) Βενζιμιδαζολο-θειοφαινικες ενωσεις ως plk αναστολεις
DE602005023877D1 (de) Verfahren zur herstellung von 7-alpha-alkylierte 19-norsteroide
EP2535058A3 (en) Stabilization of vaccines by lyophilization
DE502004002571D1 (de) Substituierte 3-pyrrolidin-indol-derivate
EA200900267A1 (ru) КОМПОЗИЦИЯ ДЛЯ АЭРОЗОЛЬНОЙ ИНГАЛЯЦИИ β-АГОНИСТОВ И СТЕРОИДОВ
EA201001196A1 (ru) Соединения 4-пиридинона и их применение для лечения рака
WO2007076087A3 (en) 3-aryl-substituted quinazolones, and uses thereof
EA200800393A1 (ru) Новые соединения-аналоги камптотецина, способ их получения и фармацевтические композиции, которые их содержат
WO2011069037A3 (en) Stabilization and storage of biological pharmaceutical compositions
DK1869038T3 (da) Substituerede 5,6,7,8-tetrahydro-imidazol[1,2-a]pyridin-2-ylamin-forbindelser og deres anvendelse til fremstilling af lægemidler
UY29999A1 (es) "n-pirazinil-fenilsulfonamidas, procedimientos y compuestos intemedios utilizados en su preparacion, composiciones farmaceuticas que las contienen y aplicaciones"